Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Mai 2018 09:10 ET | Quelle: Pfenex, Inc.

Pfenex to Present at the Jefferies 2018 Global Healthcare Conference

SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the Jefferies 2018 Global Healthcare Conference in New York City. ...
29. Mai 2018 09:10 ET | Quelle: Pfenex, Inc.

Pfenex Announces Closing of Public Offering of 7,820,000 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
23. Mai 2018 09:10 ET | Quelle: Pfenex, Inc.

Pfenex Announces Pricing of Offering of 6,800,000 Shares of Common Stock

SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
22. Mai 2018 16:23 ET | Quelle: Pfenex, Inc.

Pfenex Announces Offering of Common Stock

SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...

Vorherige Seite